Latest Period
Q2 2026
Security Snapshot
Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 per share (KTTA) Institutional Ownership
CUSIP: 70261F202
13F Institutional Holders and Ownership History from Q1 2024 to Q2 2026
Institutions Reporting
24
Shares (Excl. Options)
16,787,049
Price
$0.52
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- KTTA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 16,787,049
- Total 13F value
- $8,661,880
- Portfolio coverage rank
- 0%
- Share change
- +3,968,281
- Value change
- +$2,045,156
- Number of holders
- 24
- Shares outstanding
- 92,960,340
- SEC-reported price per share
- $0.45
- Insider filing price
- $0.45
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- KTTA - Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 per share is tracked under CUSIP 70261F202.
- 24 institutions reported positions in Q2 2026.
- 14 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 21 to 24 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $9,515,703 to $8,661,880.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 24 institutions filings for Q2 2026.
Security key
70261F202
Latest holder period
Q2 2026
13F holders
24
13D/G owners
14
CIK / CUSIP context first
Open Q2 2026 holders
KTTA full holder history
Pasithea Therapeutics Corp. SEC filings
Pasithea Therapeutics Corp. company facts
Pasithea Therapeutics Corp. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 70261F202:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
14
Security
KTTA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 10% | $7,160,756 | 10,229,652 | JANUS HENDERSON GROUP PLC | 28 Nov 2025 | |||
| Vivo Opportunity Fund Holdings, L.P. | 10% | 0% | $4,550,502 | -$4,054,127 | 9,286,738 | -47% | Vivo Opportunity Fund Holdings, L.P. | 30 Jun 2026 |
| Coastlands Capital LP | 11% | +15% | $2,339,371 | +$878,565 | 3,835,035 | +60% | Coastlands Capital LP | 09 Apr 2026 |
| Adage Capital Management, L.P. | 10% | $2,050,179 | 2,329,749 | Adage Capital Management, L.P. | 31 Dec 2025 | |||
| Squadron Capital Management LLC | 9.9% | 0% | $2,050,179 | +$67,601 | 2,329,749 | +3.4% | Squadron Master Fund LP | 31 Dec 2025 |
| Opaleye Management Inc. | 6.1% | -38% | $1,004,500 | -$216,090 | 2,050,000 | -18% | Opaleye Management Inc. | 30 Jun 2026 |
| Stonepine Capital Management, LLC | 5.8% | $1,366,785 | 1,952,550 | Stonepine Capital Management, LLC | 17 Jun 2026 | |||
| Funicular Funds, LP | 7.4% | $1,416,424 | 1,839,512 | Funicular Funds, LP | 15 Apr 2026 | |||
| AMERIPRISE FINANCIAL INC | 5.4% | -38% | $1,026,681 | -$440,216 | 1,350,896 | -30% | Ameriprise Financial, Inc. | 31 Mar 2026 |
| CVI Investments, Inc. | 3.8% | -61% | $791,995 | +$64,987 | 899,994 | +8.9% | CVI Investments, Inc. | 31 Dec 2025 |
| Orca Capital AG | 4.9% | -13% | $613,228 | -$14,002 | 362,857 | -2.2% | Orca Capital AG | 07 May 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $537,188 | 317,863 | Mitchell P. Kopin | 06 May 2025 | |||
| ARMISTICE CAPITAL, LLC | 5% | -50% | $240,119 | +$14,019 | 142,082 | +6.2% | Armistice Capital, LLC | 31 Mar 2025 |
| STEINMAN LAWRENCE | 3.1% | $141,720 | 83,858 | Lawrence Steinman | 01 Mar 2025 |
As of 30 Jun 2026, 24 institutional investors reported holding 16,787,049 shares of Pasithea Therapeutics Corp. - Common Stock, par value $0.0001 per share (KTTA). This represents 18% of the company’s total 92,960,340 outstanding shares.
13F concentration
Top 24 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
18%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Cable Car Capital, LP | 3.2% | 3,000,000 | +149% | 0.03% | $1,546,200 |
| Stonepine Capital Management, LLC | 2.4% | 2,201,468 | +165% | 0.87% | $1,134,637 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.3% | 2,100,000 | 0% | 0% | $1,082,340 |
| Jupiter Topco LLC | 2.3% | 2,100,000 | 0% | 0% | $1,092,315 |
| Opaleye Management Inc. | 2.2% | 2,050,000 | 0.1% | $1,056,570 | |
| AMERIPRISE FINANCIAL INC | 2% | 1,864,485 | +38% | 0% | $960,955 |
| Squadron Capital Management LLC | 1.1% | 1,000,000 | -52% | 0.18% | $515,400 |
| AdvisorShares Investments LLC | 1% | 937,550 | +178% | 0.06% | $483,213 |
| Vivo Capital, LLC | 0.5% | 465,471 | -78% | 0.02% | $239,904 |
| Persistent Asset Partners Ltd | 0.31% | 290,555 | 0% | 0.05% | $149,752 |
| UBS Group AG | 0.2% | 188,111 | +619% | 0% | $96,877 |
| XTX Topco Ltd | 0.14% | 127,572 | +278% | 0% | $65,751 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.14% | 126,279 | +135% | 0% | $65,034 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.09% | 83,856 | -19% | 0% | $43,221 |
| RENAISSANCE TECHNOLOGIES LLC | 0.07% | 65,600 | -30% | 0% | $33,810 |
| TWO SIGMA INVESTMENTS, LP | 0.07% | 64,166 | +205% | 0% | $33,071 |
| VANGUARD FIDUCIARY TRUST CO | 0.05% | 43,860 | 0% | 0% | $22,588 |
| NORTHERN TRUST CORP | 0.03% | 31,405 | +62% | 0% | $16,186 |
| Jump Financial, LLC | 0.03% | 29,363 | 0% | $15,133 | |
| Tower Research Capital LLC (TRC) | 0.01% | 8,838 | +377% | 0% | $4,555 |
| Hurley Capital, LLC | 0.01% | 7,000 | +90% | 0% | $3,608 |
| SBI Securities Co., Ltd. | 0% | 1,051 | 0% | 0% | $542 |
| BARCLAYS PLC | 0% | 269 | 0% | $139 | |
| JPMORGAN CHASE & CO | 0% | 150 | 0% | 0% | $79 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 16,787,049 | $8,661,880 | +$2,045,156 | $0.52 | 24 |
| 2026 Q1 | 12,818,768 | $9,515,703 | -$559,110 | $0.74 | 21 |
| 2025 Q4 | 12,892,082 | $16,641,289 | +$13,193,231 | $1.29 | 24 |
| 2025 Q3 | 612,004 | $441,403 | +$224,539 | $0.73 | 18 |
| 2025 Q2 | 300,344 | $216,624 | +$151,923 | $0.72 | 10 |
| 2025 Q1 | 78,704 | $99,102 | -$116,583 | $1.30 | 7 |
| 2024 Q4 | 77,162 | $243,273 | +$214,440 | $3.15 | 7 |
| 2024 Q3 | 9,086 | $48,891 | -$103,371 | $5.42 | 6 |
| 2024 Q2 | 29,996 | $151,569 | -$300 | $5.06 | 7 |
| 2024 Q1 | 30,055 | $218,102 | +$218,102 | $7.28 | 6 |